Drug information for MOXIFLOXACIN HYDROCHLORIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION; OPHTHALMIC
0.5%
Tentative Approval
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin
TEVA PHARMS
78073
SOLUTION; OPHTHALMIC
0.5%
Tentative Approval
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin
APOTEX INC
90080
TABLET; ORAL
400MG
Tentative Approval
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin
TORRENT PHARMS LTD
200160
TABLET; ORAL
400MG
Tentative Approval
(Reference Drug)
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin
DR REDDYS LABS LTD
76938
TABLET; ORAL
400MG
Tentative Approval
MOXIFLOXACIN HYDROCHLORIDE
moxifloxacin
TEVA PHARMS
77437
Drug Adverse Effects information for MOXIFLOXACIN HYDROCHLORIDE
Role code
Indications
Reaction
# Reports
SS
INFECTION
CYTOLYTIC HEPATITIS
1
SS
INFECTION
PSEUDOMONAS INFECTION
1
SS
INFECTION
SUPERINFECTION
1
SS
LEGIONELLA INFECTION
CYTOLYTIC HEPATITIS
2
SS
LEGIONELLA INFECTION
PSEUDOMONAS INFECTION
2
SS
LEGIONELLA INFECTION
SUPERINFECTION
2
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD MAGNESIUM DECREASED
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
CYTOLYTIC HEPATITIS
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
ELECTROCARDIOGRAM QT PROLONGED
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
ELECTROCARDIOGRAM T WAVE ABNORMAL
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
LOSS OF CONSCIOUSNESS
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
PSEUDOMONAS INFECTION
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATORY TRACT INFECTION
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
SUPERINFECTION
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
VENTRICULAR TACHYCARDIA
3
SS
STAPHYLOCOCCAL INFECTION
CYTOLYTIC HEPATITIS
1
SS
STAPHYLOCOCCAL INFECTION
PSEUDOMONAS INFECTION
1
SS
STAPHYLOCOCCAL INFECTION
SUPERINFECTION
1
SS
SUPERINFECTION
CYTOLYTIC HEPATITIS
1
SS
SUPERINFECTION
PSEUDOMONAS INFECTION
1
SS
SUPERINFECTION
SUPERINFECTION
1
C
AGE-RELATED MACULAR DEGENERATION
CEREBRAL INFARCTION
1
C
ANTIBIOTIC PROPHYLAXIS
ABDOMINAL DISCOMFORT
2
C
ANTIBIOTIC PROPHYLAXIS
BLOOD GLUCOSE INCREASED
2
C
ANTIBIOTIC PROPHYLAXIS
DIARRHOEA
2
C
ANTIBIOTIC PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
ANTIBIOTIC PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
ANTIBIOTIC PROPHYLAXIS
EPISTAXIS
2
C
ANTIBIOTIC PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ANTIBIOTIC PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
ANTIBIOTIC PROPHYLAXIS
ORAL HERPES
2
C
ANTIBIOTIC PROPHYLAXIS
PLEURISY
2
C
ANTIBIOTIC PROPHYLAXIS
PNEUMONIA
2
C
ANTIBIOTIC PROPHYLAXIS
PRURITUS
2
C
ANTIBIOTIC PROPHYLAXIS
PYREXIA
2
C
ANTIBIOTIC PROPHYLAXIS
RENAL FAILURE ACUTE
2
C
ANTIBIOTIC PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
2
C
ANTIBIOTIC PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
2
C
ANTIBIOTIC PROPHYLAXIS
VOMITING
2
C
ANTIBIOTIC PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
2
C
ANTIFUNGAL PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
ANTIFUNGAL PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
ANTIFUNGAL PROPHYLAXIS
DIARRHOEA
1
C
ANTIFUNGAL PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
ANTIFUNGAL PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
ANTIFUNGAL PROPHYLAXIS
EPISTAXIS
1
C
ANTIFUNGAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
ANTIFUNGAL PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
ANTIFUNGAL PROPHYLAXIS
ORAL HERPES
1
C
ANTIFUNGAL PROPHYLAXIS
PLEURISY
1
C
ANTIFUNGAL PROPHYLAXIS
PNEUMONIA
1
C
ANTIFUNGAL PROPHYLAXIS
PRURITUS
1
C
ANTIFUNGAL PROPHYLAXIS
PYREXIA
1
C
ANTIFUNGAL PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
ANTIFUNGAL PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
ANTIFUNGAL PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
ANTIFUNGAL PROPHYLAXIS
VOMITING
1
C
ANTIFUNGAL PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
ANTIVIRAL PROPHYLAXIS
ABDOMINAL DISCOMFORT
2
C
ANTIVIRAL PROPHYLAXIS
BLOOD GLUCOSE INCREASED
2
C
ANTIVIRAL PROPHYLAXIS
DIARRHOEA
2
C
ANTIVIRAL PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
ANTIVIRAL PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
ANTIVIRAL PROPHYLAXIS
EPISTAXIS
2
C
ANTIVIRAL PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
ANTIVIRAL PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
ANTIVIRAL PROPHYLAXIS
ORAL HERPES
2
C
ANTIVIRAL PROPHYLAXIS
PLEURISY
2
C
ANTIVIRAL PROPHYLAXIS
PNEUMONIA
2
C
ANTIVIRAL PROPHYLAXIS
PRURITUS
2
C
ANTIVIRAL PROPHYLAXIS
PYREXIA
2
C
ANTIVIRAL PROPHYLAXIS
RENAL FAILURE ACUTE
2
C
ANTIVIRAL PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
2
C
ANTIVIRAL PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
2
C
ANTIVIRAL PROPHYLAXIS
VOMITING
2
C
ANTIVIRAL PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
2
C
APLASTIC ANAEMIA
ABDOMINAL DISCOMFORT
2
C
APLASTIC ANAEMIA
BLOOD GLUCOSE INCREASED
2
C
APLASTIC ANAEMIA
DIARRHOEA
2
C
APLASTIC ANAEMIA
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
APLASTIC ANAEMIA
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
APLASTIC ANAEMIA
EPISTAXIS
2
C
APLASTIC ANAEMIA
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
APLASTIC ANAEMIA
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
APLASTIC ANAEMIA
ORAL HERPES
2
C
APLASTIC ANAEMIA
PLEURISY
2
C
APLASTIC ANAEMIA
PNEUMONIA
2
C
APLASTIC ANAEMIA
PRURITUS
2
C
APLASTIC ANAEMIA
PYREXIA
2
C
APLASTIC ANAEMIA
RENAL FAILURE ACUTE
2
C
APLASTIC ANAEMIA
STAPHYLOCOCCAL SEPSIS
2
C
APLASTIC ANAEMIA
STEVENS-JOHNSON SYNDROME
2
C
APLASTIC ANAEMIA
VOMITING
2
C
APLASTIC ANAEMIA
WHITE BLOOD CELL COUNT DECREASED
2
C
BONE MARROW CONDITIONING REGIMEN
ABDOMINAL DISCOMFORT
6
C
BONE MARROW CONDITIONING REGIMEN
BLOOD GLUCOSE INCREASED
6
C
BONE MARROW CONDITIONING REGIMEN
DIARRHOEA
6
C
BONE MARROW CONDITIONING REGIMEN
DIFFUSE LARGE B-CELL LYMPHOMA
6
C
BONE MARROW CONDITIONING REGIMEN
DISSEMINATED INTRAVASCULAR COAGULATION
6
C
BONE MARROW CONDITIONING REGIMEN
EPISTAXIS
6
C
BONE MARROW CONDITIONING REGIMEN
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
6
C
BONE MARROW CONDITIONING REGIMEN
GRAFT VERSUS HOST DISEASE IN SKIN
6
C
BONE MARROW CONDITIONING REGIMEN
ORAL HERPES
6
C
BONE MARROW CONDITIONING REGIMEN
PLEURISY
6
C
BONE MARROW CONDITIONING REGIMEN
PNEUMONIA
6
C
BONE MARROW CONDITIONING REGIMEN
PRURITUS
6
C
BONE MARROW CONDITIONING REGIMEN
PYREXIA
6
C
BONE MARROW CONDITIONING REGIMEN
RENAL FAILURE ACUTE
6
C
BONE MARROW CONDITIONING REGIMEN
STAPHYLOCOCCAL SEPSIS
6
C
BONE MARROW CONDITIONING REGIMEN
STEVENS-JOHNSON SYNDROME
6
C
BONE MARROW CONDITIONING REGIMEN
VOMITING
6
C
BONE MARROW CONDITIONING REGIMEN
WHITE BLOOD CELL COUNT DECREASED
6
C
CONSTIPATION PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
CONSTIPATION PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
CONSTIPATION PROPHYLAXIS
DIARRHOEA
1
C
CONSTIPATION PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
CONSTIPATION PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
CONSTIPATION PROPHYLAXIS
EPISTAXIS
1
C
CONSTIPATION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
CONSTIPATION PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
CONSTIPATION PROPHYLAXIS
ORAL HERPES
1
C
CONSTIPATION PROPHYLAXIS
PLEURISY
1
C
CONSTIPATION PROPHYLAXIS
PNEUMONIA
1
C
CONSTIPATION PROPHYLAXIS
PRURITUS
1
C
CONSTIPATION PROPHYLAXIS
PYREXIA
1
C
CONSTIPATION PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
CONSTIPATION PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
CONSTIPATION PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
CONSTIPATION PROPHYLAXIS
VOMITING
1
C
CONSTIPATION PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
ENDOTRACHEAL INTUBATION
ABDOMINAL DISCOMFORT
3
C
ENDOTRACHEAL INTUBATION
BLOOD GLUCOSE INCREASED
3
C
ENDOTRACHEAL INTUBATION
DIARRHOEA
3
C
ENDOTRACHEAL INTUBATION
DIFFUSE LARGE B-CELL LYMPHOMA
3
C
ENDOTRACHEAL INTUBATION
DISSEMINATED INTRAVASCULAR COAGULATION
3
C
ENDOTRACHEAL INTUBATION
EPISTAXIS
3
C
ENDOTRACHEAL INTUBATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
3
C
ENDOTRACHEAL INTUBATION
GRAFT VERSUS HOST DISEASE IN SKIN
3
C
ENDOTRACHEAL INTUBATION
ORAL HERPES
3
C
ENDOTRACHEAL INTUBATION
PLEURISY
3
C
ENDOTRACHEAL INTUBATION
PNEUMONIA
3
C
ENDOTRACHEAL INTUBATION
PRURITUS
3
C
ENDOTRACHEAL INTUBATION
PYREXIA
3
C
ENDOTRACHEAL INTUBATION
RENAL FAILURE ACUTE
3
C
ENDOTRACHEAL INTUBATION
STAPHYLOCOCCAL SEPSIS
3
C
ENDOTRACHEAL INTUBATION
STEVENS-JOHNSON SYNDROME
3
C
ENDOTRACHEAL INTUBATION
VOMITING
3
C
ENDOTRACHEAL INTUBATION
WHITE BLOOD CELL COUNT DECREASED
3
C
GASTRITIS PROPHYLAXIS
ABDOMINAL DISCOMFORT
4
C
GASTRITIS PROPHYLAXIS
BLOOD GLUCOSE INCREASED
4
C
GASTRITIS PROPHYLAXIS
DIARRHOEA
4
C
GASTRITIS PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
4
C
GASTRITIS PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
4
C
GASTRITIS PROPHYLAXIS
EPISTAXIS
4
C
GASTRITIS PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
GASTRITIS PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
4
C
GASTRITIS PROPHYLAXIS
ORAL HERPES
4
C
GASTRITIS PROPHYLAXIS
PLEURISY
4
C
GASTRITIS PROPHYLAXIS
PNEUMONIA
4
C
GASTRITIS PROPHYLAXIS
PRURITUS
4
C
GASTRITIS PROPHYLAXIS
PYREXIA
4
C
GASTRITIS PROPHYLAXIS
RENAL FAILURE ACUTE
4
C
GASTRITIS PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
4
C
GASTRITIS PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
4
C
GASTRITIS PROPHYLAXIS
VOMITING
4
C
GASTRITIS PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
4
C
HIV INFECTION
CYTOLYTIC HEPATITIS
1
C
HIV INFECTION
DRUG INTOLERANCE
1
C
HIV INFECTION
ENTEROCOCCUS TEST POSITIVE
1
C
HIV INFECTION
HEPATIC ARTERY THROMBOSIS
1
C
HIV INFECTION
HEPATIC NECROSIS
1
C
HIV INFECTION
HEPATITIS FULMINANT
1
C
HIV INFECTION
LIVER TRANSPLANT
1
C
HIV INFECTION
PERITONEAL HAEMORRHAGE
1
C
HIV INFECTION
PERITONITIS BACTERIAL
1
C
HIV INFECTION
PYREXIA
1
C
HIV INFECTION
STAPHYLOCOCCAL INFECTION
1
C
HYPERKALAEMIA
BLOOD PRESSURE DECREASED
1
C
HYPERKALAEMIA
CHILLS
1
C
HYPERKALAEMIA
PHLEBITIS
1
C
HYPERKALAEMIA
PYREXIA
1
C
HYPERTENSION
BLOOD PRESSURE DECREASED
1
C
HYPERTENSION
CHILLS
1
C
HYPERTENSION
PHLEBITIS
1
C
HYPERTENSION
PYREXIA
1
C
HYPERURICAEMIA
BLOOD PRESSURE DECREASED
1
C
HYPERURICAEMIA
CHILLS
1
C
HYPERURICAEMIA
PHLEBITIS
1
C
HYPERURICAEMIA
PYREXIA
1
C
INFECTION PROPHYLAXIS
ABDOMINAL DISCOMFORT
1
C
INFECTION PROPHYLAXIS
BLOOD GLUCOSE INCREASED
1
C
INFECTION PROPHYLAXIS
DIARRHOEA
1
C
INFECTION PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
INFECTION PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
INFECTION PROPHYLAXIS
EPISTAXIS
1
C
INFECTION PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
INFECTION PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
INFECTION PROPHYLAXIS
ORAL HERPES
1
C
INFECTION PROPHYLAXIS
PLEURISY
1
C
INFECTION PROPHYLAXIS
PNEUMONIA
1
C
INFECTION PROPHYLAXIS
PRURITUS
1
C
INFECTION PROPHYLAXIS
PYREXIA
1
C
INFECTION PROPHYLAXIS
RENAL FAILURE ACUTE
1
C
INFECTION PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
1
C
INFECTION PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
1
C
INFECTION PROPHYLAXIS
VOMITING
1
C
INFECTION PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
1
C
KIDNEY TRANSPLANT REJECTION
BLOOD PRESSURE DECREASED
4
C
KIDNEY TRANSPLANT REJECTION
CHILLS
4
C
KIDNEY TRANSPLANT REJECTION
PHLEBITIS
4
C
KIDNEY TRANSPLANT REJECTION
PYREXIA
4
C
MULTIPLE SCLEROSIS
BLISTER
1
C
MULTIPLE SCLEROSIS
INJECTION SITE INFLAMMATION
1
C
MULTIPLE SCLEROSIS
INJECTION SITE NECROSIS
1
C
PREMEDICATION
ABDOMINAL DISCOMFORT
4
C
PREMEDICATION
BLOOD GLUCOSE INCREASED
4
C
PREMEDICATION
DIARRHOEA
4
C
PREMEDICATION
DIFFUSE LARGE B-CELL LYMPHOMA
4
C
PREMEDICATION
DISSEMINATED INTRAVASCULAR COAGULATION
4
C
PREMEDICATION
EPISTAXIS
4
C
PREMEDICATION
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
4
C
PREMEDICATION
GRAFT VERSUS HOST DISEASE IN SKIN
4
C
PREMEDICATION
ORAL HERPES
4
C
PREMEDICATION
PLEURISY
4
C
PREMEDICATION
PNEUMONIA
4
C
PREMEDICATION
PRURITUS
4
C
PREMEDICATION
PYREXIA
4
C
PREMEDICATION
RENAL FAILURE ACUTE
4
C
PREMEDICATION
STAPHYLOCOCCAL SEPSIS
4
C
PREMEDICATION
STEVENS-JOHNSON SYNDROME
4
C
PREMEDICATION
VOMITING
4
C
PREMEDICATION
WHITE BLOOD CELL COUNT DECREASED
4
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE DECREASED
4
C
PRODUCT USED FOR UNKNOWN INDICATION
CHILLS
4
C
PRODUCT USED FOR UNKNOWN INDICATION
PHLEBITIS
4
C
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
4
C
PROPHYLAXIS
ABDOMINAL DISCOMFORT
8
C
PROPHYLAXIS
BLOOD GLUCOSE INCREASED
8
C
PROPHYLAXIS
BLOOD PRESSURE DECREASED
1
C
PROPHYLAXIS
CHILLS
1
C
PROPHYLAXIS
DIARRHOEA
8
C
PROPHYLAXIS
DIFFUSE LARGE B-CELL LYMPHOMA
8
C
PROPHYLAXIS
DISSEMINATED INTRAVASCULAR COAGULATION
8
C
PROPHYLAXIS
EPISTAXIS
8
C
PROPHYLAXIS
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
8
C
PROPHYLAXIS
GRAFT VERSUS HOST DISEASE IN SKIN
8
C
PROPHYLAXIS
ORAL HERPES
8
C
PROPHYLAXIS
PHLEBITIS
1
C
PROPHYLAXIS
PLEURISY
8
C
PROPHYLAXIS
PNEUMONIA
8
C
PROPHYLAXIS
PRURITUS
8
C
PROPHYLAXIS
PYREXIA
9
C
PROPHYLAXIS
RENAL FAILURE ACUTE
8
C
PROPHYLAXIS
STAPHYLOCOCCAL SEPSIS
8
C
PROPHYLAXIS
STEVENS-JOHNSON SYNDROME
8
C
PROPHYLAXIS
VOMITING
8
C
PROPHYLAXIS
WHITE BLOOD CELL COUNT DECREASED
8
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ABDOMINAL DISCOMFORT
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
BLOOD GLUCOSE INCREASED
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DIARRHOEA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
EPISTAXIS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
ORAL HERPES
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PLEURISY
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PNEUMONIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PRURITUS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
PYREXIA
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
RENAL FAILURE ACUTE
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
STAPHYLOCOCCAL SEPSIS
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
STEVENS-JOHNSON SYNDROME
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
VOMITING
2
C
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE
WHITE BLOOD CELL COUNT DECREASED
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
ABDOMINAL DISCOMFORT
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
BLOOD GLUCOSE INCREASED
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DIARRHOEA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
EPISTAXIS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
ORAL HERPES
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PLEURISY
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PNEUMONIA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PRURITUS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PYREXIA
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
RENAL FAILURE ACUTE
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
STAPHYLOCOCCAL SEPSIS
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
STEVENS-JOHNSON SYNDROME
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
VOMITING
2
C
PROPHYLAXIS OF NAUSEA AND VOMITING
WHITE BLOOD CELL COUNT DECREASED
2
C
RENAL IMPAIRMENT
ABDOMINAL DISCOMFORT
1
C
RENAL IMPAIRMENT
BLOOD GLUCOSE INCREASED
1
C
RENAL IMPAIRMENT
DIARRHOEA
1
C
RENAL IMPAIRMENT
DIFFUSE LARGE B-CELL LYMPHOMA
1
C
RENAL IMPAIRMENT
DISSEMINATED INTRAVASCULAR COAGULATION
1
C
RENAL IMPAIRMENT
EPISTAXIS
1
C
RENAL IMPAIRMENT
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
1
C
RENAL IMPAIRMENT
GRAFT VERSUS HOST DISEASE IN SKIN
1
C
RENAL IMPAIRMENT
ORAL HERPES
1
C
RENAL IMPAIRMENT
PLEURISY
1
C
RENAL IMPAIRMENT
PNEUMONIA
1
C
RENAL IMPAIRMENT
PRURITUS
1
C
RENAL IMPAIRMENT
PYREXIA
1
C
RENAL IMPAIRMENT
RENAL FAILURE ACUTE
1
C
RENAL IMPAIRMENT
STAPHYLOCOCCAL SEPSIS
1
C
RENAL IMPAIRMENT
STEVENS-JOHNSON SYNDROME
1
C
RENAL IMPAIRMENT
VOMITING
1
C
RENAL IMPAIRMENT
WHITE BLOOD CELL COUNT DECREASED
1
C
SEDATIVE THERAPY
ABDOMINAL DISCOMFORT
2
C
SEDATIVE THERAPY
BLOOD GLUCOSE INCREASED
2
C
SEDATIVE THERAPY
DIARRHOEA
2
C
SEDATIVE THERAPY
DIFFUSE LARGE B-CELL LYMPHOMA
2
C
SEDATIVE THERAPY
DISSEMINATED INTRAVASCULAR COAGULATION
2
C
SEDATIVE THERAPY
EPISTAXIS
2
C
SEDATIVE THERAPY
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER
2
C
SEDATIVE THERAPY
GRAFT VERSUS HOST DISEASE IN SKIN
2
C
SEDATIVE THERAPY
ORAL HERPES
2
C
SEDATIVE THERAPY
PLEURISY
2
C
SEDATIVE THERAPY
PNEUMONIA
2
C
SEDATIVE THERAPY
PRURITUS
2
C
SEDATIVE THERAPY
PYREXIA
2
C
SEDATIVE THERAPY
RENAL FAILURE ACUTE
2
C
SEDATIVE THERAPY
STAPHYLOCOCCAL SEPSIS
2
C
SEDATIVE THERAPY
STEVENS-JOHNSON SYNDROME
2
C
SEDATIVE THERAPY
VOMITING
2
C
SEDATIVE THERAPY
WHITE BLOOD CELL COUNT DECREASED
2
C
TRANSPLANT REJECTION
BLOOD PRESSURE DECREASED
2
C
TRANSPLANT REJECTION
CHILLS
2
C
TRANSPLANT REJECTION
PHLEBITIS
2
C
TRANSPLANT REJECTION
PYREXIA
2
Ads by Google